Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Cancer Res. 2010 Jan 12;70(2):552–559. doi: 10.1158/0008-5472.CAN-09-2653

Figure 2.

Figure 2

Receiver operating characteristic (ROC) curves for MelaPRO-HBI, MelaPRO-LBI, MelaPRO-GEM and MELPREDICT (using leave-one-out cross-validation) on the Boston validation set. Also shown are the true positive and false positive fractions associated with the summary family history criterion: FH.